Michael Ciesielski -  SurVax-M 2010-08-31 10@0,33x
Buffalo New York UNITED STATES
Dr. Ciesielski is a co-inventor of the survivin vaccine technology on which MimiVax was founded. He joined the Academic Faculty of Roswell Park Cancer Institute (RPCI) in 2004 after obtaining his Ph.D. in Immunology from the State University of New York at Buffalo. Prior to this, he established the Neuro-Oncology laboratory together with Dr. Fenstermaker in 1995. Dr. Ciesielski is also an Assistant Professor of Neurosurgery and Oncology at Roswell Park Cancer Institute and member of the Graduate Faculty of the University at Buffalo School of Medicine and Biomedical Sciences. He has co-authored more than 47 journal articles and numerous abstracts. Dr. Ciesielski holds 10 global patents, nine of which are for the survivin technology.